LAMC2 and non-small cell lung carcinoma: Consistently, the higher levels of COL7A1 and LAMC2 are correlated with HIF-1 activation in NSCLC carrying p53 mutations, and associated with a poor prognosis of the patients (Amelio et al., 2018).